We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$20.8B
AUM Growth
+$3.81B
Cap. Flow
+$2.41B
Cap. Flow %
11.56%
Top 10 Hldgs %
30.36%
Holding
2,920
New
199
Increased
391
Reduced
1,521
Closed
76

Sector Composition

Rank Sector Weight
1 Technology 30.99%
2 Financials 13.3%
3 Consumer Discretionary 10.8%
4 Healthcare 9.36%
5 Industrials 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OBK icon
1701
Origin Bancorp
OBK
$1.69B
$611K ﹤0.01%
17,713
IMKTA icon
1702
Ingles Markets
IMKTA
$1.67B
$608K ﹤0.01%
8,735
PRO
1703
DELISTED
PROS Holdings
PRO
$606K ﹤0.01%
26,433
-1,093
-4% -$17.8K
CSR
1704
Centerspace
CSR
$944M
$605K ﹤0.01%
10,267
-6
-0.1% -$347
SCL icon
1705
Stepan Co
SCL
$1.48B
$604K ﹤0.01%
12,659
PFBC icon
1706
Preferred Bank
PFBC
$1.28B
$601K ﹤0.01%
6,651
-896
-12% -$83.1K
CRI icon
1707
Carter's
CRI
$1.43B
$601K ﹤0.01%
21,303
LMB icon
1708
Limbach Holdings
LMB
$541M
$601K ﹤0.01%
6,184
HSII
1709
DELISTED
Heidrick & Struggles
HSII
$598K ﹤0.01%
12,021
WS icon
1710
Worthington Steel
WS
$1.96B
$598K ﹤0.01%
19,668
ONON icon
1711
On Holding
ONON
$10.6B
$597K ﹤0.01%
14,103
+407
+3% +$19.4K
STOK icon
1712
Stoke Therapeutics
STOK
$1.97B
$595K ﹤0.01%
25,320
+1,457
+6% +$25K
ROOT icon
1713
Root
ROOT
$795M
$589K ﹤0.01%
6,575
+155
+2% +$16.2K
IART icon
1714
Integra LifeSciences
IART
$1.41B
$588K ﹤0.01%
41,050
AIV
1715
Aimco
AIV
$379M
$588K ﹤0.01%
74,096
-7,051
-9% -$57.3K
DRVN icon
1716
Driven Brands
DRVN
$2.13B
$587K ﹤0.01%
36,437
KW
1717
DELISTED
Kennedy-Wilson Holdings
KW
$587K ﹤0.01%
70,498
-2,176
-3% -$17.5K
ESRT icon
1718
Empire State Realty Trust
ESRT
$829M
$584K ﹤0.01%
76,249
-7,315
-9% -$55.9K
DHC
1719
Diversified Healthcare Trust
DHC
$2.03B
$584K ﹤0.01%
132,390
-1,035
-0.8% -$3.94K
JANX icon
1720
Janux Therapeutics
JANX
$966M
$584K ﹤0.01%
23,876
AMLX icon
1721
Amylyx Pharmaceuticals
AMLX
$2.45B
$583K ﹤0.01%
42,929
ECVT icon
1722
Ecovyst
ECVT
$1.12B
$582K ﹤0.01%
66,451
REAL icon
1723
The RealReal
REAL
$1.33B
$582K ﹤0.01%
54,715
-4,658
-8% -$34.5K
CBRL icon
1724
Cracker Barrel
CBRL
$1.29B
$581K ﹤0.01%
13,188
DFTX
1725
Definium Therapeutics
DFTX
$5.78B
$580K ﹤0.01%
49,196

Similar funds

MetLife Investment Management's Q3 2025 Portfolio in Review

As of Q3 2025, MetLife Investment Management held 2,920 positions worth $20.8B, up 22% from $17B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

MetLife Investment Management deployed $2.41B of net new capital in Q3 2025, opening 199 new positions and adding to 391 existing holdings. Its largest new stake was Apple: 4,311,733 shares worth $1.1B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $37.1M trimmed.

  • MetLife Investment Management's largest Q3 2025 buy was Apple: 4,311,733 shares worth $1.1B.
  • MetLife Investment Management added most to Applovin in Q3 2025, an estimated $29.1M increase.
  • MetLife Investment Management's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $37.1M.
  • MetLife Investment Management fully exited RTX Corp in Q3 2025, selling an estimated $49.7M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.8B portfolio in Q3 2025.
  • MetLife Investment Management opened 199 new positions and closed 76 in Q3 2025.
  • MetLife Investment Management's portfolio value rose 22% quarter-over-quarter to $20.8B.

Based on MetLife Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.